+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID07844460

Using 3D Magnetic Resonance Elastography to Assess Vestibular Schwannoma Tumor Properties and Surgical Features

Led by Shengjing Hospital · Updated on 2026-10-16

30

Participants Needed

1

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of three-dimensional magnetic resonance elastography 3D MRE to assess tumor stiffness and adhesion in patients with vestibular schwannoma undergoing surgical removal. The study aims to determine if 3D MRE can serve as a noninvasive tool to predict tumor behavior and surgical difficulty by comparing imaging results with surgical and histological findings and patient outcomes. Participants will receive routine preoperative MRI along with an additional 3D MRE scan to measure tumor stiffness and adhesion characteristics. During surgery, neurosurgeons will record tumor stiffness, adhesion, vascularity, and surgical difficulty. After surgery, facial nerve function and other clinical outcomes will be followed up for 3 to 6 months to examine relationships with MRE findings. Participants will undergo preoperative imaging, surgery, and postoperative clinical evaluations including facial nerve function assessments. Researchers will analyze correlations between MRE data, surgical observations, tissue analysis, and patient recovery. The main measure is how well MRE stiffness matches the tumor consistency observed during surgery. This study lasts until March 2027 and aims to help improve surgical planning and patient counseling for vestibular schwannoma.

CONDITIONS

Brief Title

3D MRE-Based Evaluation of Vestibular Schwannoma Mechanical Properties and Histological Features

Research Team

W

wen Cheng, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here